CCIV Symposium 2023
Location: HSRB-II, N100
Join us for the annual CCIV symposium, where internal and external speakers will share the latest research on infectious diseases, microbial pathogens, immune responses, and the development of new vaccines and therapeutics.
Date and Time
Monday, December 4, 2023 | 1:00 pm - 6:00 pm
Health Sciences Research Building II, Room N100
Please register to help us plan the conference room layout and reception: https://www.surveymonkey.com/r/8Y5YC5Y
1:00 pm - 1:50 pm | Keynote Presentation: Dr. Theresa Alenghat, Cincinnati Children's Hospital | "Regulation of the Host-Microbiota Relationship" | HSRB-II Room N100
1:50 pm - 2:10 pm | Internal Speaker: Dr. Cynthia Whitney, Professor, Rollins School of Public Health | "What infectious diseases cause stillbirths and child deaths in high-mortality settings? Results from Child Health and Mortality Prevention Surveillance (CHAMPS)" | HSRB-II Room N100
2:20 pm - 3:10 pm | Breakout Sessions
- Inclusive Leadership and Conflict Management | Moderators: Drs. Andi Shane, Andres Camacho-Gonzalez, and Paul Thomas | HSRB-II Room N100
- Research in the Virtual Environment: Delivering Engaging Presentations and Building Collaborations | Moderators: Drs. Mehul Suthar, Christina Rostad, and Theresa Alenghat | HSRB-II Room N147
- Sustainability in Bench Science and Clinical Research | Moderators: Dr. Preeti Jaggi and Justin Bright (Green Labs Program) | HSRB-II Room N257
3:20 pm - 3:40 pm | Internal Speaker: Dr. Natalie Dean, Assistant Professor and Co-Director, Emory Alliance for Vaccine Epidemiology (EAVE), Rollins School of Public Health | "Considerations for the Test Negative Design for Evaluating Vaccine Effectiveness" | HSRB-II Room N100
3:40 pm - 4:25 pm | Oral Abstract Presentations | HSRB-II Room N100
- 3:40 - 3:55 | Dr. Devyani Joshi "Durable Antibody Responses After SARS-CoV-2 Infection in Infants/Young Children"
- 3:55 - 4:10 | Dr. Lauren Middlebrooks, "The Impact of Implementing Opt-Out HIV Screening in Adolescents Presenting in the Pediatric Emergency Department in Metro Atlanta"
- 4:10 - 4:25 | Dr. David Prikryl, "Cyclosporines Promote Virus Entry by Modulating Cellular Trafficking of IFITM Proteins"
4:30 pm - 5:20 pm | Keynote Presentation: Dr. Paul G. Thomas, St. Jude Children's Research Hospital | "Predicting Influenza Protection and Pathology from Baseline Immune Profiles" | HSRB-II Room N100
5:20 pm - 6:00 pm | Poster Session/Reception | HSRB-II 1st Floor Atrium
"Regulation of the Host-Microbiota Relationship"
Dr. Theresa Alenghat, Cincinnati Children's Hospital
Dr. Theresa Alenghat investigates epithelial and immune cell homeostasis in the context of intestinal health and disease. The goals of her lab are to provide insight into molecular mechanisms, including epigenomic pathways, that mediate the host-microbiota relationship. Dr. Alenghat aims to determine how this level of regulation affects innate immunity, enteric infections in neonates and children, and chronic conditions such as inflammatory bowel disease.
"Predicting Influenza Protection and Pathology from Baseline Immune Profiles"
Dr. Paul G. Thomas, St. Jude Children's Research Hospital
Following his postdoctoral training with Nobel laureate Dr. Peter Doherty, Dr. Paul G. Thomas joined the faculty of the Department of Immunology at St. Jude Children's Research Hospital in 2009. His work has been instrumental in generating new understanding of T cell receptor specificity and defining key elements of innate and adaptive immune responses that determine clinical outcomes to viral infections. Dr. Thomas leads several complex institutional programs including human influenza surveillance efforts and virtual repository development, and currently serves as PI for the 7-year, 12-institution DIVINCI consortium. In addition to his scientific achievements, Dr. Thomas is widely regarded for his mentorship and empowerment of junior scientists.
"What infectious diseases cause stillbirths and child deaths in high-mortality settings? Results from Child Health and Mortality Prevention Surveillance (CHAMPS)"
Dr. Cynthia Whitney, Child Health and Mortality Prevention Surveillance (CHAMPS) Program, Emory University
Dr. Whitney became the Principal Investigator and Executive Director of the Child Health and Mortality Prevention Surveillance (CHAMPS) program in 2020. CHAMPS is a large multicounty program operating in 7 countries that generates accurate information on causes of child mortality using cutting-edge diagnostic techniques; CHAMPS is based in the Emory Global Health Institute. Dr. Whitney became a Professor at Emory University in the Rollins School of Public Health, Hubert Department of Global Health in 2019. Before that, she was Chief of the Respiratory Diseases Branch in the Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, and had worked for 25 years at the U.S. Centers for Disease Control and Prevention in Atlanta, Georgia, USA. Click on the links to learn more about Dr. Whitney and CHAMPS.
"Considerations for the Test Negative Design for Evaluating Vaccine Effectiveness"
Dr. Natalie Dean, Emory Alliance for Vaccine Epidemiology (EAVE), Emory University
Dr. Natalie Dean is an Assistant Professor in the Department of Biostatistics and Bioinformatics at Emory’s Rollins School of Public Health. She received her PhD in Biostatistics from Harvard University and previously worked as a consultant for the WHO’s HIV Department and as a faculty at the University of Florida. Her primary research area is infectious disease epidemiology, with a focus on innovative study designs for evaluating vaccines during public health emergencies. She is co-director of the Emory Alliance for Vaccine Epidemiology and a PI of Emory’s CDC-funded Center for Innovation in Outbreak Analytics. During the COVID-19 pandemic, she was active in public engagement, with authored pieces in the Washington Post, New York Times, and other outlets. She received the 2024 Communications Award from the Joint Policy Board for Mathematics. Click on the links to learn more about Dr. Dean and EAVE.